参考文献/References:
[1]Ogawa R.Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis[J].Int J Mol Sci,2017,18(3):606. [2]Pavelecini M,Zettler CG,Fernandes MC.Immunohistochemical Expression of Cyclo- oxygenases in Hypertrophic Scars and Keloids[J].Plastic and Reconstructive Surgery,2019,7(2):2030. [3]Abdou AG,Maraee AH,Saif H.Immunohistochemical evaluation of COX-1 and COX-2 expression in keloid and hypertrophic scar[J].The American Journal of Dermato-pathology,2014,36(4):311-317. [4]Zhou J,Zhao Y,Simonenko V,et al.Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis[J].Oncotarget,2017,8(46):80651-80665. [5]Rossiello L,DAndrea F,Grella R,et al.Differential expression of cyclooxygen-ases in hypertrophic scar and keloid tissues[J].Wound Repair Regen,2009,17(5):750-757. [6]Suzuki S,Fujita N,Hosogane N,et al.Excessive reactive oxygen species are therapeutic targets for intervertebral disc degeneration[J].Arthritis Res Ther,2015(17):316. [7]Yang JH,Yoon JY,Moon J,et al.Expression of inflammatory and fibrogenetic markers in acne hypertrophic scar formation: focusing on role of TGF-β and IGF-1R[J].Arch Dermatol Res,2018,310(8):665-673. [8]Chen L,Wang J,Li S,et al.The clinical dynamic changes of macrophage phenotype and function in different stages of human wound healing and hypertrophic scar formation[J].Int Wound J,2019,16(2):360-369. [9]Grellner W,Georg T,Wilske J.Quantitative analysis of proinflammatory cytokines(IL-1beta,IL-6,TNF-alpha)in human skin wounds[J].Forensic Sci Int,2000,113(1-3):251-264. [10]Jun-Zeng,Huang TY,Wang ZZ,et al.Scar-reducing effects of gambogenic acid on skin wounds in rabbit ears[J].Int Immunopharmacol,2020:107200. [11]de Bakker E,van der Putten MAM,Heymans MW,et al.Prognostic tools for hypertrophic scar formation based on fundamental differences in systemic immunity[J].Exp Dermatol,2021,30(1):169-178. [12]Nguyen JK,Austin E,Huang A,et al.The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets[J].Arch Dermatol Res,2020,312(2):81-92. [13]Hedayatyanfard K,Haddadi NS,Ziai SA,et al.The renin-angiotensin system in cutaneous hypertrophic scar and keloid formation[J].Exp Dermatol,2020,29(9):902-909. [14]郭果香,冯红霞,辛燕.己酮可可碱对人瘢痕疙瘩成纤维细胞IL-6、PDGF表达的影响[J].中国冶金工业医学杂志,2016,33(5):590-591. [15]Jundi K,Greene CM.Transcription of Interleukin-8:How Altered Regulation Can Affect Cystic Fibrosis Lung Disease[J].Biomolecules,2015,5(3):1386-1398. [16]Xie F,Teng L,Xu J,et al.Interleukin-10 modified bone marrow mesenchymal stem cells prevent hypertrophic scar formation by inhibiting inflammation[J].Pharmazie,2020,75(11):571-575. [17]Berman B.Biological agents for controlling excessive scarring[J].Am J Clin Dermatol,2010,11 (Suppl 1):31-34. [18]Viera MH,Vivas AC,Berman B.Update on Keloid Management: Clinical and Basic Science Advances[J].Adv Wound Care (New Rochelle),2012,1(5):200-206. [19]Yang Z,Lv Y,Yue F,et al.Early intervention of fractional carbon dioxide laser on fresh traumatic scar[J].Lasers Med Sci,2019,34(7):1317-1324. [20]Wang J,Jiao H,Stewart TL,et al.Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes[J].Interferon Cytokine Res,2007,27(11):921-930. [21]Yang L,Scott PG,Dodd C,et al.Identification of fibrocytes in postburn hypertro-phic scar[J].Wound Repair Regen,2005,13(4):398-404. [22]Finnerty CC,Jeschke MG,Branski LK,et al.Hypertrophic scarring:the greatest unmet challenge after burn injury[J].Lancet,2016,388(10052):1427-1436. [23]Lucas T,Waisman A,Ranjan R,et al.Differential roles of macrophages in diverse phases of skin repair[J].Immunol,2010,184(7):3964-3977. [24]Zhu Z,Ding J,Ma Z,et al.Systemic depletion of macrophages in the subacute phase of wound healing reduces hypertrophic scar formation[J].Wound Repair Regen,2016,24(4):644-656. [25]Lateef Z,Stuart G,Jones N,et al.The Cutaneous Inflammatory Response to Thermal Burn Injury in a Murine Model[J].Int J Mol Sci,2019,20(3):538. [26]Braga TT,Agudelo JS,Camara NO.Macrophages During the Fibrotic Process:M2 as Friend and Foe[J].Front Immunol,2015(6):602. [27]Wilgus TA,Ud-Din S,Bayat A.A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis[J].Int J Mol Sci,2020,21(24):E9673. [28]Wulff BC,Parent AE,Meleski MA,et al.Mast cells contribute to scar formation during fetal wound healing[J].Invest Dermatol,2012,132(2):458-465. [29]Chen H,Xu Y,Yang G,et al.Mast cell chymase promotes hypertrophic scar fibroblast proliferation and collagen synthesis by activating TGF-β1/Smads signaling pathway[J].Exp Ther Med,2017,14(5):4438-4442. [30]Ma L,Li LY,Zhao TL.Anti-inflammatory effects of ginsenoside Rg3 on the hypertrophic scar formation via the NF-κB/IκB signaling pathway in rabbit ears[J].Pharmazie,2020,75(2):102-106. [31]Medina JL,Sebastian EA,Fourcaudot AB,et al.Pirfenidone Ointment Modulates the Burn Wound Bed in C57BL/6 Mice by Suppressing Inflammatory Responses[J].Inflammation,2019,42(1):45-53. [32]Jiao H,Fan J,Cai J,et al.Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients[J].Aesthetic Plast Surg,2015,39(5):818-825. [33]Kwan PO,Tredget EE.Biological Principles of Scar and Contracture[J].Hand Clin,2017,33(2):277-292. [34]邵家松,孟德峰,岳毅刚,等.饲服环磷酰胺对兔耳早期增生性瘢痕组织的影响[J].中华整形外科杂志,2011(6):437-442. [35]Wong VW,Rustad KC,Akaishi S,et al.Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling[J].Nat Med,2011,18(1):148-152. [36]Wang CH,Chang SJ,Tzeng YS,et al.Enhanced wound-healing performance of a phyto-polysaccharide-enriched dressing - a preclinical small and large animal study[J].Int Wound J,2017,14(6):1359-1369. [37]Liu XJ,Xu MJ,Fan ST,et al.Xiamenmycin attenuates hypertrophic scars by suppressing local inflammation and the effects of mechanical stress[J].Invest Dermatol,2013,133(5):1351-1360. [38]Murphy A,LeVatte T,Boudreau C,et al.Angiotensin II Type I Receptor Blockade Is Associated with Decreased Cutaneous Scar Formation in a Rat Model[J].Plast Reconstr Surg,2019,144(5):803-813.